Back

Sex differences in clinical characteristics and outcomes after transcatheter patent foramen ovale closure

19 February 2026 (08:00 - 18:30)
Organised by: Logo
Congress Presentation Part of: The inter-atrial septum: a therapeutic target Patent Foramen Ovale (PFO) / Atrial Septal Defect (ASD) Closure EAPCI Premium Access EAPCI Summit 2026 European Association of Percutaneous Cardiovascular Interventions (EAPCI)

About the speaker

Photo
Doctor Carlo Gaspardone

University Vita-Salute San Raffaele, Milan (Italy)

5 More presentations in this session

Presentation thumbnail
Tailoring antiplatelet therapy duration after PFO closure: insights from the PROLONG registry
Doctor C. Gaspardone (Milan, IT)
Abstract Slides
Presentation thumbnail
Effectiveness of intraprocedural guidance modalities on PFO closure outcomes: insights from the PROLONG registry
Doctor C. Gaspardone (Milan, IT)
Abstract Slides
Presentation thumbnail
Long term outcomes of patent foramen ovale closure in elderly patients
Doctor D. D'Atri (Mainz, DE)
Abstract Slides
Presentation thumbnail
Atrial arrhythmias after PFO closure: a randomized, controlled, investigator-inititiated, multicentre study (ASPARAGUS) - preliminary results.
Assistant Professor A. Pietrasik (Warsaw, PL)
Abstract Slides
Presentation thumbnail
Clinical and hemodynamic outcomes of transcatheter iatrogenic atrial shunting in patients with heart failure: a systematic review and meta-analysis
Doctor N. Pyrpyris (Athens, GR)
Abstract Slides

Access the full session

Session thumbnail
The inter-atrial septum: a therapeutic target

The Event

Event poster

EAPCI Summit 2026

19 February - 20 February 2026
You may be interested in
thumbnail
Congress Presentation
A reversible cause of heart failure?
thumbnail
Congress Presentation
Navigating anatomical barriers: successful amplatzer closure of a high-risk patent foramen ovale after failed noblestitch
thumbnail
Congress Presentation
Anatomical classification of patent foramen ovale before percutaneous closure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources